BioMarin Pharmaceutical Reports Third-Quarter Revenue of $1.02 Billion
Story updates
09:03:07 PM UTC
SquawkNews
BioMarin Pharmaceutical 3Q Loss/Shr 63c >BMRN
09:03:30 PM UTC
SquawkNews
Third Quarter 2026 Total Revenues Increased 32% Y/Y to $1.025 billion; Growth Driven by 44% Increase in Metabolic Conditions Y/Y, and 12% Increase in Skeletal Conditions Y/YUpdates Full-year 2026 Guidance to Reflect Order Timing Uncertainty and Impact of Two Acquired In-process Research and Develop…
09:06:24 PM UTC
SquawkNews
Third Quarter 2026 Total Revenues Increased 32% Y/Y to $1.025 billion; Growth Driven by 44% Increase
09:07:23 PM UTC
SquawkNews
*-- Earnings Flash (BMRN) BioMarin Pharmaceutical Inc. Reports Q3 Revenue $1.02B, vs.